IN8bio, Inc. Profile Avatar - Palmy Investing

IN8bio, Inc.

IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologou…

Biotechnology
US, New York [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of INAB's Analysis
CIK: 1740279 CUSIP: 45674E109 ISIN: US45674E1091 LEI: - UEI: -
Secondary Listings
INAB has no secondary listings inside our databases.